review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Bronte V | |
Forni G | |||
Tura S | |||
Zanon P | |||
Bocchia M | |||
Colombo MP | |||
Lemoli RM | |||
Di Nicola M | |||
Rondelli D | |||
Massaia M | |||
De Vincentiis A | |||
Lanata L | |||
P433 | issue | 11 | |
P304 | page(s) | 1172-1206 | |
P577 | publication date | 2000-11-01 | |
P1433 | published in | Haematologica | Q5638209 |
P1476 | title | Antitumor vaccination: where we stand | |
P478 | volume | 85 |
Q37428422 | A novel non-Hodgkin lymphoma murine model closer to the standard clinical scenario |
Q33517133 | Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model |
Q34859794 | Cancer immunotherapy and breaking immune tolerance: new approaches to an old challenge. |
Q59796509 | Co-expression of IL-15 enhances anti-neuroblastoma effectivity of a tyrosine hydroxylase-directed DNA vaccination in mice |
Q81846523 | Comparison of protective effect of protein and DNA vaccines hsp90 in murine model of systemic candidiasis |
Q34110774 | Early expression of stem cell-associated genes within the CD8 compartment after treatment with a tumor vaccine |
Q47965988 | Gene cloning of murine alpha-fetoprotein gene and construction of its eukaryotic expression vector and expression in CHO cells |
Q36907752 | Identification of HLA-A24-restricted CD8(+) cytotoxic T-cell epitopes derived from mammaglobin-A, a human breast cancer-associated antigen |
Q45160017 | Identification of inhibitors of myeloid-derived suppressor cells activity through phenotypic chemical screening |
Q51012673 | Interleukin-15 enhances T-cell responses by stimulation with dendritic cells. |
Q40516283 | Poly (I:C) enhances the anti-tumor activity of canine parvovirus NS1 protein by inducing a potent anti-tumor immune response. |
Q49395392 | Salmonella Immunotherapy Improves the Outcome of CHOP Chemotherapy in Non-Hodgkin Lymphoma-Bearing Mice. |
Q36421292 | Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE), is highly active against primary uterine serous papillary carcinoma cell lines in vitro. |
Q36171935 | Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE®), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitro |
Q35007586 | Solitomab, an epithelial cell adhesion molecule/CD3 bispecific antibody (BiTE), is highly active against primary chemotherapy-resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivo |
Q30915166 | The efficacy of adjuvant immunochemotherapy with OK-432 after curative resection of gastric cancer: an individual patient data meta-analysis of randomized controlled trials |
Q36694952 | Transduction of dendritic cells with recombinant adenovirus encoding HCA661 activates autologous cytotoxic T lymphocytes to target hepatoma cells |
Q38269469 | Viral genes as oncolytic agents for cancer therapy |
Search more.